In the CNS, altered PDE4 activity has been linked to neuropsychiatric disorders, while PDE5 dysfunction is implicated in neurodegenerative conditions such as Alzheimer’s disease and cerebrovascular disorders like stroke [3,27,28]. Here, PDE4A is linked to early-onset autosomal dominant Alzheimer disease.